Viridian Therapeutics, Inc. Financial Ratios — VRDN Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-138.14	- -	- -	-72.79	-124.81	- -	- -	-84.66	-97.35	-75.17	-63.87
Return on Assets (%)	- -	-66.94	-134.16	-107.93	-147.71	-93.45	-55.14	-86.87	-137.09	-47.42	-40.66	-51.37	-43.79	-41.73
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	30.95	35.63	22.08	2.6	23.64	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-66.96	-6.93	-157.94	-433.53	-284.24	-655.11	-391.16	-934.57	-3,836.19	-2,686.74	-7,564.84	-80,868.79	-98,839.4	-512.27
Operating Margin (%)	-70.24	-10.36	-161.27	-440.78	-289.9	-662.8	-394.51	-941.02	-3,858.95	-2,690.79	-7,579.23	-81,035.03	-99,018.21	-512.91
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-127.51	-50.05	-182.64	-446.34	-379.8	-662.3	-389.97	-938.65	-10,544.29	-2,680.16	-7,329.23	-75,711.46	-89,387.09	-483.57
Profit Margin (%)	-163.67	-50.05	-182.64	-446.34	-379.8	-662.3	-389.97	-938.65	-10,544.29	-2,680.16	-7,329.23	-75,711.46	-89,387.09	-483.57
Net Income to Common Margin (%)	-163.67	-56.65	-182.64	-446.34	-379.8	-662.3	-389.97	-938.65	-10,544.29	-2,680.16	-7,329.23	-75,711.46	-89,387.09	-483.57
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	-12.82	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-138.14	- -	- -	-72.79	-124.81	- -	- -	-84.66	-97.35	-75.17	-63.87

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	23	27	- -	1	1	10	10	8	- -	1	5	21	21	51
ST Debt	23	27	- -	1	1	- -	2	4	- -	1	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	10	8	4	- -	- -	5	20	21	50
Total Debt/EBITDA	-7.67	-89	-0.01	-0.1	-0.11	-0.38	-0.31	-0.2	-0.01	-0.01	-0.04	-0.08	-0.07	-0.14
Net Debt/EBITDA	-7.63	-88.3	0.75	0.88	0.24	1.43	0.68	0.4	1.14	0.53	1.13	0.33	0.26	0.45
Total Debt/EBIT	-7.31	-59.53	-0.01	-0.1	-0.11	-0.37	-0.31	-0.2	-0.01	-0.01	-0.04	-0.08	-0.07	-0.14
Net Debt/EBIT	-7.28	-59.06	0.73	0.87	0.24	1.41	0.67	0.39	1.13	0.53	1.12	0.32	0.26	0.45
EBITDA to Interest Expense	-1.85	-0.15	-6.67	-78.04	-99.84	-68.47	-37.58	-49.93	-79.29	-26,536	-275.82	-190.78	-135.86	-73.35
EBITDA-CapEx/Interest Expense	-1.92	-0.15	-6.93	-78.91	-99.87	-69.11	-38.08	-50.03	-79.37	-26,648.67	-277.46	-191.45	-136.1	-73.45
EBIT to Interest Expense	-1.94	-0.23	-6.81	-79.34	-101.83	-69.27	-37.9	-50.27	-79.76	-26,576	-276.35	-191.17	-136.11	-73.44
Interest Expense	2	2	1	- -	- -	- -	1	1	1	- -	- -	1	2	5
Common Equity/Total Assets	-771.12	-650.34	74.06	80.69	-7.65	73.38	77.62	52.06	-46.29	26.45	58.13	48.02	65.03	65.61
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	25.76	15.59	27.47	- -	- -	1.18	4.57	3.06	6.92
Long-Term Debt/Capital (%)	3.54	- -	- -	- -	- -	20.49	12.98	17.99	- -	- -	1.16	4.36	2.97	6.46
Long-Term Debt/Total Assets (%)	1.51	- -	- -	- -	- -	18.91	12.1	14.3	- -	- -	1.07	4.12	2.77	5.55
Total Debt/Equity (%)	-105.54	-111.4	1.34	10.61	-320.55	25.76	20.06	52.71	0.38	0.28	1.33	4.76	3.14	7.02
Total Debt/Capital (%)	1,906.42	976.91	1.32	9.6	145.34	20.49	16.71	34.52	0.38	0.28	1.31	4.55	3.05	6.56
Total Debt/Total Assets (%)	813.81	724.5	0.99	8.56	24.54	18.91	15.57	27.44	0.35	0.26	1.21	4.29	2.84	5.64
Net Debt to Equity	-105.01	-110.53	-85.44	-93.44	704.29	-97.43	-43.45	-105	-38.24	-22.53	-38.2	-18.69	-11.76	-22.49
Net Debt/Capital (%)	2,095.61	1,049.78	-537.71	-1,424.16	87.57	-3,785.97	-76.83	2,099.24	-61.53	-28.98	-61.67	-22.94	-13.32	-28.98
EBITDA	-3	- -	-7	-11	-9	-26	-33	-42	-40	-80	-134	-254	-298	-363
EBITDA-CapEx	-3	- -	-7	-11	-9	-26	-33	-42	-40	-80	-135	-255	-299	-363
Operating Income (Loss)	-3	- -	-7	-11	-10	-27	-33	-42	-41	-80	-134	-254	-299	-363

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.01	2.57	4.39	0.73	12.17	9.28	2.64	11.96	14.44	12.73	17.92	14.99	12.37
Current Ratio	0.07	0.08	3.41	4.75	0.93	13.31	9.71	2.92	12.14	14.68	12.93	18.26	15.43	12.65
Quick Ratio	0.06	0.04	3.12	4.55	0.84	12.55	9.28	2.65	11.96	14.48	12.73	17.93	14.99	12.37
CFO/Avg Current Liab	- -	-0.05	-0.15	-3.1	-2.05	-6.64	-5.05	-4.26	-2.86	-4.49	-3.99	-6.14	-6.24	-4.66
Common Equity/Total Assets	-771.12	-650.34	74.06	80.69	-7.65	73.38	77.62	52.06	-46.29	26.45	58.13	48.02	65.03	65.61
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	25.76	15.59	27.47	- -	- -	1.18	4.57	3.06	6.92
Long-Term Debt/Capital (%)	3.54	- -	- -	- -	- -	20.49	12.98	17.99	- -	- -	1.16	4.36	2.97	6.46
Long-Term Debt/Total Assets (%)	1.51	- -	- -	- -	- -	18.91	12.1	14.3	- -	- -	1.07	4.12	2.77	5.55
Total Debt/Equity (%)	-105.54	-111.4	1.34	10.61	-320.55	25.76	20.06	52.71	0.38	0.28	1.33	4.76	3.14	7.02
Total Debt/Capital (%)	1,906.42	976.91	1.32	9.6	145.34	20.49	16.71	34.52	0.38	0.28	1.31	4.55	3.05	6.56
Total Debt/Total Assets (%)	813.81	724.5	0.99	8.56	24.54	18.91	15.57	27.44	0.35	0.26	1.21	4.29	2.84	5.64
CFO/Total Liabilities	-25.7	-4.24	-105.48	-276.81	-157.71	-201.61	-181.34	-248.52	-265.46	-341.28	-234.44	-380.5	-328.3	-155.93
CFO/CapEx	-58.22	-233.6	-8.32	-56.08	-2,410.33	-114.5	-60.32	-429.24	-709.02	-161.48	-117.74	-205.09	-454.64	-558.37
Altman's Z-Score	-22.35	-16.58	- -	-1.84	-16.39	7.12	0.65	-10.74	0.82	15.1	16.6	11.92	11.07	8.49

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	3.94	4.15	3.43	7.27	4.04	11.33	67.59	19.44	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	92.59	87.95	106.57	50.21	90.27	32.21	5.4	18.77	- -	- -	- -	- -	- -
Inventory Turnover	- -	10.55	12.56	13.51	20.3	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	34.59	29.06	27.02	17.98	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	46.82	17.96	9.98	12.09	-0.12	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	7.8	20.32	36.57	30.18	-3,036.91	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	119.38	96.69	97.01	38	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	58	58.89	79.55	32.23	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	10	8	4	235	93	17	70	473	1,207	1,176	1,553	3,169
- Cash & Cash Equivalents	- -	- -	5	11	3	47	33	25	46	42	156	103	100	212
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	181	134	142	207	189	132
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	23	27	- -	1	1	10	10	8	- -	1	5	21	21	51
Enterprise Value	23	26	5	-2	1	198	41	-2	123	410	929	926	1,045	2,477
Total Capital	1	3	6	12	1	48	62	24	120	188	400	463	693	773
Total Debt/Capital (%)	1,906.42	976.91	1.32	9.6	145.34	20.49	16.71	34.52	0.38	0.28	1.31	4.55	3.05	6.56
Total Debt / EV	1	1.01	0.02	-0.62	0.73	0.05	0.25	-4.59	- -	- -	0.01	0.02	0.02	0.02
EV/Sales	5.11	6.12	1.06	- -	0.43	49.43	4.92	- -	117.35	138.5	524.49	2,949.08	3,460.44	34.96
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	33.21	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	33	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	6	6	4	201	90	15	59	236	937	975	1,301	2,639
Diluted Enterprise Value	23	26	1	-4	1	163	67	-2	194	328	929	1,100	1,412	2,609
EV per Share	1,339.41	1,570.52	271.76	- -	28.75	131.51	20.07	- -	29.12	17.15	22.5	17.15	12.9	24.33
TTM Sales	4	4	4	3	3	4	8	4	1	3	2	- -	- -	71
TTM EBITDA	-3	- -	-7	-11	-9	-26	-33	-42	-40	-80	-134	-254	-298	-363
TTM Operating Income	-3	- -	-7	-11	-10	-27	-33	-42	-41	-80	-134	-254	-299	-363
TTM Cash Flow to Firm	-5	1	-1	-7	-7	-28	-26	-35	-29	-55	-93	-183	-230	-271
TTM Free Cash Flow to Firm	-5	1	-1	-7	-7	-28	-26	-35	-29	-54	-93	-182	-230	-271

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-2.94	-0.89	-0.5	-7.19	-3.4	-0.42	-1.97	-4.34	-10.07	-5.32	-5.61	-9.57
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	23	26	5	-2	1	198	41	-2	123	410	929	926	1,045	2,477
Low Price	- -	- -	474.75	149.18	27	71.4	33	6.6	4.67	10.44	9.47	10.92	11.4	9.9
EV/Sales	5.11	6.12	1.06	- -	0.43	49.43	4.92	- -	117.35	138.5	524.49	2,949.08	3,460.44	34.96
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.27	-1.2	-0.44	-7.7	-5.52	-1.46	-0.43	-2.59	-4.55	-4.35	-4.48	-4.73
Price/Earnings High	- -	- -	-2.86	-4.14	-0.86	-13.07	-9.4	-3.71	-1.09	-3.85	-7.41	-7.34	-6.84	-8.43
Price/Earnings Low	- -	- -	-0.6	-0.47	-0.1	-3.46	-1.99	-0.33	-0.15	-1.57	-2.34	-2.06	-2.87	-2.45
Price/Book Value	- -	- -	1.6	0.76	-11.41	6.11	1.82	1.06	-1.15	8.78	4.77	4.99	3.22	5.37
Price/Book Value Average	- -	- -	2.82	1.72	-17.68	6.22	3.67	4.31	-0.92	7.67	3.01	5.29	2.99	3.29
Price/Book Value High	- -	- -	6.31	5.92	-34.4	10.55	6.23	10.98	-2.37	11.4	4.9	8.94	4.56	5.87
Price/Book Value Low	- -	- -	1.33	0.68	-4.1	2.79	1.32	0.97	-0.33	4.64	1.55	2.5	1.91	1.71
Price/Tangible Book Value	- -	- -	1.6	0.76	-11.41	6.11	1.82	1.06	-1.15	8.78	4.77	4.99	3.22	5.37
Price/Tangible Book Value Average	- -	- -	2.82	1.72	-17.68	6.22	3.67	4.31	-0.92	7.67	3.01	5.29	2.99	3.29
Price/Tangible Book Value High	- -	- -	6.31	5.92	-34.4	10.55	6.23	10.98	-2.37	11.4	4.9	8.94	4.56	5.87
Price/Tangible Book Value Low	- -	- -	1.33	0.68	-4.1	2.79	1.32	0.97	-0.33	4.64	1.55	2.5	1.91	1.71
Price/Sales	- -	- -	1.33	2.38	1.08	50.14	10.7	3.37	55.73	79.53	528.93	3,104.38	4,309.18	37.25
Price/Sales Average	- -	- -	2.33	5.37	1.68	51.01	21.54	13.68	44.93	69.45	333.76	3,292.3	4,007.38	22.85
Price/Sales High	- -	- -	5.22	18.49	3.27	86.54	36.64	34.84	115.35	103.26	543.06	5,558.8	6,114.22	40.74
Price/Sales Low	- -	- -	1.1	2.11	0.39	22.88	7.77	3.09	15.82	42	171.48	1,557.18	2,562.58	11.85
Price/Cash Flow	- -	- -	-2.59	-0.88	-0.5	-7.13	-3.34	-0.42	-1.96	-4.32	-9.99	-5.29	-5.6	-9.55
Price/Cash Flow Average	- -	- -	-4.55	-1.98	-0.77	-7.25	-6.73	-1.69	-1.58	-3.77	-6.3	-5.61	-5.21	-5.86
Price/Cash Flow High	- -	- -	-10.18	-6.8	-1.51	-12.3	-11.45	-4.31	-4.07	-5.61	-10.25	-9.48	-7.95	-10.44
Price/Cash Flow Low	- -	- -	-2.15	-0.78	-0.18	-3.25	-2.43	-0.38	-0.56	-2.28	-3.24	-2.65	-3.33	-3.04
Price/Free Cash Flow Average	- -	- -	-5.17	-2.01	-0.78	-7.31	-6.84	-1.7	-1.59	-3.79	-6.36	-5.64	-5.22	-5.87
Price/Free Cash Flow High	- -	- -	-11.57	-6.93	-1.51	-12.41	-11.64	-4.32	-4.07	-5.64	-10.34	-9.52	-7.97	-10.46
Price/Free Cash Flow Low	- -	- -	-2.44	-0.79	-0.18	-3.28	-2.47	-0.38	-0.56	-2.29	-3.27	-2.67	-3.34	-3.04
EV/Sales Average	5.11	6.12	2.74	3.23	1.04	50.45	19.78	11.51	182.36	170.48	425.04	4,368.58	5,146.69	27.02
EV/Sales High	5.11	6.12	7.58	20.47	2.67	92.11	35.51	35.05	266.12	238.33	694.46	7,102.53	7,660.34	48.51
EV/Sales Low	5.11	6.12	0.68	- -	- -	17.46	5.43	- -	147.73	115.36	216.14	2,275.59	3,422.91	13.81
EV/EBITDA Average	-7.63	-88.3	-1.73	-0.75	-0.37	-7.7	-5.06	-1.23	-4.75	-6.35	-5.62	-5.4	-5.21	-5.27
EV/EBITDA High	-7.63	-88.3	-4.8	-4.72	-0.94	-14.06	-9.08	-3.75	-6.94	-8.87	-9.18	-8.78	-7.75	-9.47
EV/EBITDA Low	-7.63	-88.3	-0.43	0.24	0.1	-2.67	-1.39	0.03	-3.85	-4.29	-2.86	-2.81	-3.46	-2.7
EV/EBIT Average	-7.28	-59.06	-1.7	-0.73	-0.36	-7.61	-5.01	-1.22	-4.73	-6.34	-5.61	-5.39	-5.2	-5.27
EV/EBIT High	-7.28	-59.06	-4.7	-4.64	-0.92	-13.9	-9	-3.73	-6.9	-8.86	-9.16	-8.76	-7.74	-9.46
EV/EBIT Low	-7.28	-59.06	-0.42	0.24	0.1	-2.63	-1.38	0.03	-3.83	-4.29	-2.85	-2.81	-3.46	-2.69
Last Price	- -	- -	571.5	168.3	75.15	156.45	45.45	7.2	16.45	19.77	29.21	21.78	19.17	31.12
High Price	- -	- -	2,247.75	1,304.78	226.65	270	155.7	74.4	34.05	25.67	29.99	39	27.2	34.04
Enterprise Value Average	23	26	12	8	3	202	166	51	191	505	753	1,372	1,554	1,914
Enterprise Value High	23	26	33	52	9	369	298	156	279	706	1,231	2,230	2,313	3,437
Enterprise Value Low	23	26	3	-3	-1	70	46	-1	155	342	383	715	1,034	978

Shares Outstanding	- -	- -	- -	- -	- -	2	2	2	4	24	41	54	81	102
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	2	2	4	12	32	45	68	85
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	2	2	4	12	32	45	68	85
Revenue per Share	355.15	344.15	430.88	70.57	69.38	3.12	4.25	2.14	0.3	0.25	0.06	0.01	- -	0.84
EBITDA per Share	-237.82	-23.84	-680.53	-305.94	-197.22	-20.44	-16.62	-19.96	-11.32	-6.68	-4.18	-5.67	-4.4	-4.28
Operating Income per Share	-249.45	-35.64	-694.89	-311.06	-201.15	-20.68	-16.77	-20.09	-11.39	-6.69	-4.19	-5.69	-4.4	-4.29
Basic EPS, GAAP	-581.27	-194.96	-786.95	-314.98	-263.53	-20.66	-16.57	-20.04	-31.13	-6.66	-4.05	-5.31	-3.98	-4.04
Basic EPS from Cont Ops	-452.87	-172.24	-786.95	-314.98	-263.53	-20.66	-16.57	-20.04	-31.13	-6.66	-4.05	-5.31	-3.98	-4.04
Diluted EPS, GAAP	-581.27	-194.96	-786.95	-314.98	-263.53	-20.66	-16.57	-20.04	-31.13	-6.66	-4.05	-5.31	-3.98	-4.04
Diluted EPS from Cont Ops	-452.87	-172.24	-786.95	-314.98	-263.53	-20.66	-16.57	-20.04	-31.13	-6.66	-4.05	-5.31	-3.98	-4.04
Dividend per Share	58.04	22.73	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-501.76	-93.13	-220.73	-191.8	-150.35	-21.95	-13.6	-17.26	-8.37	-4.58	-2.92	-4.12	-3.42	-3.26
Free Cash Flow per Basic Share	-510.38	-93.53	-247.26	-195.22	-150.41	-22.15	-13.83	-17.3	-8.38	-4.61	-2.95	-4.14	-3.43	-3.27
Cash & Equivalents per Share	6.69	12.43	304.5	229.16	67.51	31.53	30.39	11.55	30.17	8.23	10.28	8.84	8.86	8.59
Book Value per Share	-1,275.5	-1,420.91	356.37	220.23	-6.59	25.6	24.97	6.78	-14.36	2.25	6.12	4.36	5.96	5.8
Tangible Book Value per Share	-1,275.5	-1,420.91	356.37	220.23	-6.59	25.6	24.97	6.78	-14.36	2.25	6.12	4.36	5.96	5.8

Viridian Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)